Literature DB >> 10609077

Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema.

F Cantini1, C Salvarani, I Olivieri.   

Abstract

Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) is a syndrome that may be associated with many conditions, including malignancy. Three further cases of paraneoplastic RS3PE are described and the literature is reviewed. Paraneoplastic RS3PE is more frequently associated with solid tumors, in particular adenocarcinoma. The two clinical characteristics suggestive of paraneoplastic RS3PE are systemic sign/symptoms and the poor response to corticosteroid therapy.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10609077

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


  8 in total

1.  Symmetrical pitting edema resembling RS3PE in gout.

Authors:  C Palazzi; I Olivieri; E D'Amico; V Pace-Palitti; A Petricca
Journal:  Clin Rheumatol       Date:  2003-10-31       Impact factor: 2.980

2.  Magnetic resonance imaging findings in a case of remitting seronegative symmetrical synovitis with pitting edema.

Authors:  Zeliha Unlu; Sebnem Orguc; Gulgun Yilmaz Ovali; Serdar Tarhan; Idris Dayan; Aclan Angin
Journal:  Clin Rheumatol       Date:  2005-05-31       Impact factor: 2.980

Review 3.  Spondyloarthritis with onset after age 45.

Authors:  Ignazio Olivieri; Salvatore D'Angelo; Angela Padula; Pietro Leccese; Carlo Palazzi
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

4.  Acute Onset of Remitting Seronegative Symmetrical Synovitis With Pitting Edema (RS3PE) Two Weeks After COVID-19 Vaccination With mRNA-1273 With Possible Activation of Parvovirus B19: A Case Report With Literature Review.

Authors:  Hiroto Arino; Naokazu Muramae; Mitsumasa Okano; Kenta Mori; Kazunori Otsui; Kazuhiko Sakaguchi
Journal:  Cureus       Date:  2022-05-12

5.  Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema (RS3PE syndrome): a report of two cases and review of the literature.

Authors:  S Ercan Tunc; Cagatay Arslan; Naime Bayram Ayvacioglu; Mehmet Sahin; Selami Akkus; Huseyin Yorgancigil
Journal:  Rheumatol Int       Date:  2003-10-31       Impact factor: 2.631

6.  The rate of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in a clinic where primary care physicians are working in Japan.

Authors:  Toshikatsu Okumura; Satoshi Tanno; Masumi Ohhira; Tsukasa Nozu
Journal:  Rheumatol Int       Date:  2011-03-24       Impact factor: 2.631

7.  Remitting seronegative symmetrical synovitis with pitting edema syndrome induced by pembrolizumab in patient with urothelial carcinoma.

Authors:  Akihiro Yoshimura; Kazuaki Yamanaka; Rei Tadokoro; Teppei Wakita; Shota Fukae; Takahiro Yoshida; Masahiro Sekiguchi; Hidefumi Kishikawa
Journal:  IJU Case Rep       Date:  2022-05-03

8.  Novel Development of Remitting Seronegative Symmetrical Synovitis with Pitting Edema (RS3PE) Syndrome due to Insulin Therapy.

Authors:  Naba Raj Mainali; Torrey R Schmidt; Richard Alweis; David L George
Journal:  Am J Case Rep       Date:  2014-03-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.